Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amino-quinoxaline and amino-quinoline compounds for use as adenosine A2a receptor antagonists

Amino-quinoxaline and amino-quinoline compounds for use as adenosine A2a receptor antagonists

US Patent 8415353 · Granted Apr 9, 2013

Estimated economic value: $69,688,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Clotting factor preparations for delivery into tissue of the intestinal tract us2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating2024
PCSK9 antibody preparations for delivery into a lumen of the intestinal tract us2024
Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof2024
Antibody agents specific for human CD19 and uses thereof2024
Antibody/T-cell receptor chimeric constructs and uses thereof2024
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Cells expressing chimeric activating receptors and chimeric stimulating receptor2024
Clotting factor preparations for delivery into tissue of the intestinal tract us2023